Platelet-released growth factors induce the antimicrobial peptide human beta-defensin-2 in primary keratinocytes

Experimental Dermatology

Volumn 25, Issue 6, 2016, Pages 460-465

  Bayer, Andreas ^a   Lammel, Justus ^a   Rademacher, Franziska ^a   Groß, Justus ^a   Siggelkow, Markus ^b   Lippross, Sebastian ^a   Klüter, Tim ^a   Varoga, Deike ^a   Tohidnezhad, Mersedeh ^c   Pufe, Thomas ^c   Cremer, Jochen ^a   Gläser, Regine ^a   Harder, Jürgen ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Department of Psychiatry Imland Clinic Rendsburg   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Antimicrobial peptides; Cutaneous innate defense; Wound healing

Indexed keywords

BETA DEFENSIN 2; BLOCKING ANTIBODY; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; INTERLEUKIN 6 RECEPTOR; LUCIFERASE; PLATELET RELEASED GROWTH FACTOR; RNA; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; BETA DEFENSIN; DEFB4A PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IL6R PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PLATELET-RICH FIBRIN;

ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IN VIVO STUDY; KERATINOCYTE; LUCIFERASE ASSAY; MALE; PROTEIN EXPRESSION; PUNCH BIOPSY; METABOLISM; PHYSIOLOGY; PRIMARY CELL CULTURE; WOUND HEALING;

BETA-DEFENSINS; HUMANS; INTERLEUKIN-6; KERATINOCYTES; MALE; NF-KAPPA B; PLATELET-RICH FIBRIN; PRIMARY CELL CULTURE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, INTERLEUKIN-6; TRANSCRIPTION FACTOR AP-1; WOUND HEALING;

EID: 84969884812     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12966     Document Type: Article

References (74)

1. Eppley B L, Woodell J E, Higgins J. Plast Reconstr Surg 2004: 114: 1502-1508.
2. Weibric G, Buch R S R, Kleis W K G et al. Growth Factors 2002: 20: 93-97.
3. Yazawa M, Ogata H, Nakajima T et al. Cell Transplant 2003: 12: 509-518.
4. Anitua E, Andia I, Ardanza B et al. Thromb Haemost 2004: 91: 4-15.
5. van den Dolder J, Mooren R, Vloon A P G et al. Tissue Eng 2006: 12: 3067-3073.
6. Yamaguchi R, Terashima H, Yoneyama S et al. J Surg Res 2012: 173: 258-266.
7. Graziani F, Ivanovski S, Cei S et al. Clin Oral Implants Res 2006: 17: 212-219.
8. Rughetti A, Giusti I, D'Ascenzo S et al. Blood Transfus 2008: 6: 12-17.
9. Kawasumi M, Kitoh H, Siwicka K A et al. J Bone Joint Surg Br 2008: 90: 966-972.
10. Arpornmaeklong P, Kochel M, Depprich R et al. J Oral Maxillofac Surg 2004: 33: 60-70.
11. Kilian O, Flesch I, Wenisch S et al. Eur J Med Res 2004: 9: 337-344.
12. Kakudo N, Minakata T, Mitsui T et al. Plast Reconstr Surg 2008: 122: 1352-1360.
13. Spreafico A, Chellini F, Frediani B et al. J Cell Biochem 2009: 108: 1153-1165.
14. Steenvoorde P, van Doorn L P, Naves C et al. J Wound Care 2008: 17: 60-63.
15. Boman H G. J Intern Med 2003: 254: 197-215.
16. Ganz T, Lehrer R I. Curr Opin Immunol 1998: 10: 41-44.
17. Schröder J M. CMLS 1999: 56: 32-46.
18. Zasloff M. Nature 2002: 415: 389-395.
19. Harder J, Bartels J, Christophers E et al. Nature 1997: 387: 861.
20. McDermott A M, Redfern R L, Zhang B et al. Invest Ophthalmol Vis Sci 2003: 44: 1859-1865.
21. Liu L, Roberts A A, Ganz T. J Immunol 2003: 170: 575-580.
22. Harder J, Meyer-Hoffert U, Wehkamp K et al. J Invest Dermatol 2004: 123: 522-529.
23. Tsutsumi-Ishii Y, Nagaoka I. J Immunol 2003: 170: 4226-4236.
24. Mathews M, Jia H P, Guthmiller J M et al. Infect Immun 1999: 67: 2740-2745.
25. Lehmann J, Retz M, Harder J et al. BMC Infect Dis 2002: 2: 20.
26. Harder J, Meyer-Hoffert U, Teran L M et al. Am J Respir Cell Mol Biol 2000: 22: 714-721.
27. Wehkamp J, Harder J, Wehkamp K et al. Infect Immun 2004: 72: 5750-5758.
28. Kiehne K, Brunke G, Meyer D et al. Scand J Gastroenterol 2005: 40: 501-507.
29. Crack L R, Jones L, Malavige G N et al. Clin Exp Dermatol 2012: 37: 534-543.
30. Wittersheim M, Cordes J, Meyer-Hoffert U et al. Exp Dermatol 2013: 22: 364-366.
31. Rivas-Santiago B, Trujillo V, Montoya A et al. J Dermatol Sci 2012: 65: 19-26.
32. Galkowska H, Olszewski W L, Wojewodzka U. Folia Histochem Cytobiol 2005: 43: 133-136.
33. Sahly H, Schubert S, Harder J et al. J Antimicrob Chemother 2006: 57: 562-565.
34. Routsias J G, Karagounis P, Parvulesku G et al. Peptides 2010: 31: 1654-1660.
35. Huang G T-J, Zhang H-B, Kim D et al. Hum Gene Ther 2002: 13: 2017-2025.
36. Yang D, Chertov O, Bykovskaia S N et al. Science (New York, NY) 1999: 286: 525-528.
37. Niyonsaba F, Ogawa H, Nagaoka I. Immunology 2004: 111: 273-281.
38. Niyonsaba F, Ushio H, Nakano N et al. J Invest Dermatol 2007: 127: 594-604.
39. Suarez-Carmona M, Hubert P, Delvenne P et al. Cytokine Growth Factor Rev 2015: 26: 361-370.
40. Roth S A, Simanski M, Rademacher F et al. J Invest Dermatol 2014: 134: 374-380.
41. Wehkamp K, Schwichtenberg L, Schröder J-M M et al. J Invest Dermatol 2006: 126: 121-127.
42. Laudien M, Dressel S, Harder J et al. Rhinology 2011: 49: 107-111.
43. Parker C N, Finlayson K J, Shuter P et al. Int J Clin Pract 2015: 69: 1029-1030.
44. Molina-Miñano F, López-Jornet P, Camacho-Alonso F et al. Int Wound J 2009: 6: 145-148.
45. Xian L J, Chowdhury S R, Saim A B et al. Cytotherapy 2015: 17: 293-300.
46. Barsotti M C, Losi P, Briganti E et al. PLoS ONE 2013: 8: e84753.
47. Alsousou J, Ali A, Willett K et al. Platelets 2013: 24: 173-182.
48. Redler L H, Thompson S A, Hsu S H et al. Phys Sportsmed 2011: 39: 42-51.
49. Foster T E, Puskas B L, Mandelbaum B R et al. Am J Sports Med 2009: 37: 2259-2272.
50. Baeyens W, Glineur R, Evrard L. Rev Med Brux 2010: 31: 521-527.
51. Anitua E, Aguirre J J, Algorta J et al. J Biomed Mater Res 2008: 84: 415-421.
52. Orcajo B, Muruzabal F, Isasmendi M C et al. Diabetes Res Clin Pract 2011: 93: e65-e67.
53. Simanski M, Gläser R, Harder J. Exp Dermatol 2014: 23: 230-231.
54. Percoco G, Merle C, Jaouen T et al. Exp Dermatol 2013: 22: 800-806.
55. Ommori R, Ouji N, Mizuno F et al. Microb Pathog 2013: 56: 35-39.
56. Dunsche A, Açil Y, Siebert R et al. J Oral Pathol Med 2001: 30: 154-158.
57. Meyer J E, Harder J, Görögh T et al. Anticancer Res 2004: 24: 1025-1030.
58. Feng Z, Jia X, Adams M D et al. Infect Immun 2014: 82: 4458-4465.
59. Herbst R S. Int J Radiat Oncol Biol Phys 2004: 59: 21-26.
60. Carpenter G, Cohen S. J Biol Chem 1990: 265: 7709-7712.
61. Mihara M, Hashizume M, Yoshida H et al. Clin Sci 2012: 122: 143-159.
62. Rolle C E, Chen J, Pastar I et al. Immunol Res 2013: 57: 258-267.
63. Liu T, Yang F, Li Z et al. Ostomy Wound Manage 2014: 60: 30-37.
64. Kuhn K A, Manieri N A, Liu T-C et al. PLoS ONE 2014: 9: e114195.
65. Choi J-H, Jun J H, Kim J H et al. J Korean Med Sci 2014: 29(Suppl 3): S210-S216.
66. Arranz-Valsero I, Soriano-Romaní L, García-Posadas L et al. Exp Eye Res 2014: 125: 183-192.
67. Kennedy G A, Varelias A, Vuckovic S et al. Lancet Oncol 2014: 15: 1451-1459.
68. Steubesand N, Kiehne K, Brunke G et al. BMC Immunol 2009: 10: 36.
69. Shao Z-J, Zheng X-W, Feng T et al. Can J Physiol Pharmacol 2012: 90: 647-653.
70. Scharf S, Hippenstiel S, Flieger A et al. Am J Physiol 2010: 298: L687-L695.
71. Scharf S, Zahlten J, Szymanski K et al. Exp Lung Res 2012: 38: 100-110.
72. Yoon Y M, Lee J Y, Yoo D et al. Infect Immun 2010: 78: 2024-2033.
73. Tomita T, Nagase T, Ohga E et al. Respirology 2002: 7: 305-310.
74. Chuang J-Y, Huang Y-L, Yen W-L et al. Int J Mol Sci 2014: 15: 545-559.